Simplex Trading’s BioLineRX BLRX Stock Holding History

Simplex Trading’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-133	Closed	-$5K	–	8805
2024 Q1	$5K	Sell	133 -27	-17%	-$1.35K	﹤0.01%	7976
2023 Q4	$10K	Buy	160 +130	+433%	+$8.04K	﹤0.01%	7404
2023 Q3	$2K	Buy	+30	New	+$2.02K	﹤0.01%	8040

Other funds holding BLRX

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's BLRX Position: Q4 2025 in Review

Simplex Trading sold out of BioLineRX (BLRX) in Q4 2025, closing a stake of 105 shares.

Simplex Trading first reported a position in BLRX in Q4 2021 and held it in 8 quarters. The position peaked at $64K in Q2 2025. 14 funds tracked by Wall St. Rank hold BLRX as of Q4 2025.

Simplex Trading reported no remaining BioLineRX position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 105 BioLineRX shares in Q4 2025.
Simplex Trading first reported a position in BioLineRX in Q4 2021 and held it in 8 quarters.
Simplex Trading's BioLineRX position peaked at $64K in Q2 2025.
14 funds tracked by Wall St. Rank held BioLineRX as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.